The blood-derived signature models showed a trend toward better performance than the tumor-derived ones, highlighting the potential of capturing gene expression signals in whole-blood samples related to responses to ICI therapy.
← all excerpts
Immuno-Transcriptomic Profiling of Blood and Tumor Tissue Identifies Gene Signatures Associated with Immunotherapy Response in Metastatic Bladder Cancer.
1
—
—